1. Peptide-hormone and serotonin immunoreactive tumour cells in carcinoma of the prostate;Abrahamsson, P.A.; Wadstrom, L.B.; Alumets, J.; Falkmer, S.; Grimelius, L.;Pathol Res Pract,1987
2. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma;Bostwick, D.G.; Dousa, M.K.; Crawford, B.G.; Wollan, P.C.;Am Jf Surg Pathol,1994
3. Calcitonin-secreting carcinomas of the prostate. An immunohistochemical and ultrastructural analysis;Fetissof, F.; Bruandet, P.; Arbeille, B.; Penot, J.; Marboeuf, Y.; Le-Roux, J.;Am J Surg Pathol,1986
4. Prediction of response to radiotherapy in invasive bladder cancer;Jenkins, B.J.; Martin, J.E.; Baithun, S.I.; Zuk, R.J.; Oliver, R.T.D.; Blandy, J.P.;BrJ Urol,1990
5. Human chorionic gonadotrphin expression and histological findings as predictors of response to radiotherapy in carcinomas of the bladder. Virchows Arch A Pathol Anat Histopathol;Martin, J.E.; Jenkins, B.J.; Zuk, R.J.; Blandy, J.P.; Baithun, S.I.,1989